EOLS Message Board Post 9930880 | Evolus Inc.
home / stock / eols / eols message board
Cameron
(investorshub)
Posted on: Aug/02/2022 19:44:54
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169566469
$EOLS 2Q22 product_sales=$37.2M6/30/22_cash=$84.5M(down from $106.7M @3/31/22):
News, Short Squeeze, Breakout and More Instantly...
-
David Moatazedi, President and Chief Executive Officer of Evolus, is first medical aesthetics leader to be a speaker at WWD Beauty CEO Summit Evolus' flagship product, Jeuveau ® is the fastest growing aesthetic toxin in the U.S. for the last three years 1 Evolus...
-
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that its Chief Financial Officer, Sandra Beaver, has been awarded Outstanding CFO of a Public Company by the Orange County Business Journal. The awar...
-
Q1 2024 Net Revenue of $59.3 Million, Up 42% from Q1 2023 Non-GAAP Loss from Operations of $0.9 Million, on Track to Non-GAAP Profitability 1 in Q4 2024 and Full Year 2025 U.S. Clinical Trials Completed for Evolysse ® Lift and Smooth fillers, FDA Submission Expect...